Skip to main content
Journal cover image

PRIOR EXPOSURE TO A CONVENTIONAL RENIN-ANGIOTENSIN SYSTEM ANTAGONIST AND ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION IN ACUTE DECOMPENSATED HEART FAILURE: A PRESPECIFIED SUBGROUP ANALYSIS OF THE PIONEER-HF TRIAL

Publication ,  Conference
Ambrosy, AP; DeVore, A; Morrow, D; Braunwald, E; Duffy, C; McCague, K; Rocha, R; Velazquez, E
Published in: Journal of the American College of Cardiology
March 2019

Duke Scholars

Published In

Journal of the American College of Cardiology

DOI

ISSN

0735-1097

Publication Date

March 2019

Volume

73

Issue

9

Start / End Page

1020 / 1020

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ambrosy, A. P., DeVore, A., Morrow, D., Braunwald, E., Duffy, C., McCague, K., … Velazquez, E. (2019). PRIOR EXPOSURE TO A CONVENTIONAL RENIN-ANGIOTENSIN SYSTEM ANTAGONIST AND ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION IN ACUTE DECOMPENSATED HEART FAILURE: A PRESPECIFIED SUBGROUP ANALYSIS OF THE PIONEER-HF TRIAL. In Journal of the American College of Cardiology (Vol. 73, pp. 1020–1020). Elsevier BV. https://doi.org/10.1016/s0735-1097(19)31627-4
Ambrosy, Andrew P., Adam DeVore, David Morrow, Eugene Braunwald, Carolyn Duffy, Kevin McCague, Ricardo Rocha, and Eric Velazquez. “PRIOR EXPOSURE TO A CONVENTIONAL RENIN-ANGIOTENSIN SYSTEM ANTAGONIST AND ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION IN ACUTE DECOMPENSATED HEART FAILURE: A PRESPECIFIED SUBGROUP ANALYSIS OF THE PIONEER-HF TRIAL.” In Journal of the American College of Cardiology, 73:1020–1020. Elsevier BV, 2019. https://doi.org/10.1016/s0735-1097(19)31627-4.
Ambrosy AP, DeVore A, Morrow D, Braunwald E, Duffy C, McCague K, et al. PRIOR EXPOSURE TO A CONVENTIONAL RENIN-ANGIOTENSIN SYSTEM ANTAGONIST AND ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION IN ACUTE DECOMPENSATED HEART FAILURE: A PRESPECIFIED SUBGROUP ANALYSIS OF THE PIONEER-HF TRIAL. In: Journal of the American College of Cardiology. Elsevier BV; 2019. p. 1020–1020.
Ambrosy, Andrew P., et al. “PRIOR EXPOSURE TO A CONVENTIONAL RENIN-ANGIOTENSIN SYSTEM ANTAGONIST AND ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION IN ACUTE DECOMPENSATED HEART FAILURE: A PRESPECIFIED SUBGROUP ANALYSIS OF THE PIONEER-HF TRIAL.” Journal of the American College of Cardiology, vol. 73, no. 9, Elsevier BV, 2019, pp. 1020–1020. Crossref, doi:10.1016/s0735-1097(19)31627-4.
Ambrosy AP, DeVore A, Morrow D, Braunwald E, Duffy C, McCague K, Rocha R, Velazquez E. PRIOR EXPOSURE TO A CONVENTIONAL RENIN-ANGIOTENSIN SYSTEM ANTAGONIST AND ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION IN ACUTE DECOMPENSATED HEART FAILURE: A PRESPECIFIED SUBGROUP ANALYSIS OF THE PIONEER-HF TRIAL. Journal of the American College of Cardiology. Elsevier BV; 2019. p. 1020–1020.
Journal cover image

Published In

Journal of the American College of Cardiology

DOI

ISSN

0735-1097

Publication Date

March 2019

Volume

73

Issue

9

Start / End Page

1020 / 1020

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology